Our executive leadership team is composed of top-tier talent with decades of experience in technology, healthcare, and clinical trials.
Nicole Latimer is Chief Executive Officer of Medrio. As CEO, Nicole carves out her time in three equally and critically important areas: studying the life sciences industry; making decisions about how Medrio can have a greater impact on that industry, and then focusing on the best way to communicate those decisions to staff and customers.
She brings 25 years of impressive and broad-based healthcare experience, including stints at The Advisory Board Company (now part of Optum) and Deloitte Consulting where she focused on population health management, health system growth strategies, patient and employee education, and SaaS development and delivery. Most recently, in her role as CEO of Staywell, she drove the company’s mission to be the premier provider of lifestyle risk management programs for the entire healthcare ecosystem leveraging behavioral science as the foundation for improving health outcomes. She shines at redesigning processes, increasing efficiency, and reducing costs.
Nicole’s background gives her a unique perspective on the patient’s journey. She recognizes the need for technology to be user friendly and accessible for patients, while also providing accurate and complete data for clinicians. Nicole excels at observing patient and clinician behavior and applying those observations to design software and solutions that minimize queries, provide accurate data, and reduce the time spent configuring the software to allow for more focus on the patients.
Nicole received her B.A. from Dartmouth College, where she graduated with distinction. She went on to receive two graduate degrees from the Ross School of Business Administration at the University of Michigan: Master of Health Services Administration with an emphasis in Operations and Epidemiology and an MBA with an emphasis in Corporate Strategy and Marketing, graduating again with distinction.
Nicole is based in Washington, D.C. where she and her husband stay busy raising two teenage sons. In her spare time, Nicole’s passions include running, golfing, skiing, and Wolverine football (GO BLUE!).
Mike Lewis is Chief Revenue Officer with Medrio. Before joining Medrio in January 2020, his more than 20-year executive sales career brought him worldwide. With companies like the CRO Navitas, IBM, and other life science industries, he had a solid history of transforming businesses, pinpointing the root cause of underperformance and turning it around while coaching, mentoring, and training a superior sales staff. Along with a sophisticated understanding of cutting-edge technology, he had the ability to establish solid and trusted relationships with executives and clients alike.
Mike earned a BA in political science with a minor in communist comparative studies from Union College in Schenectady, NY.
With Medrio, Mike is busy transforming our sales team to ensure that our customers and prospects have the best buying experience possible. Clinical trials are expensive and complex. Mike and his team work closely with our sponsors and CROs to ensure that they are in the best position to meet the requirements both from a regulatory perspective and patient safety. Mike doesn’t believe that we are selling anything to anybody. He believes in working hard to create an atmosphere that lets our customers make the absolute best decision for their particular needs.
Ed Gould is the Chief Financial Officer of Medrio. With a demonstrated history of excellent financial performance and driving sustainable growth, Ed is a trusted financial expert with a 30+-year history of optimizing large and medium-sized organizations for aggressive growth across multiple verticals.
Prior to Medrio, Ed has held senior financial and operational leadership positions with several Private Equity- backed SaaS Software and Service companies, most recently Veriforce, SRS Health, and HCL Technologies. He also held several senior positions during a 15-year career with Reed Elsevier and started his career in the Price Waterhouse Cooper (PWC) audit group, where he focused on several large Pharmaceutical companies. In addition to his extensive experience guiding mergers and acquisitions, Ed has led teams to reach full operational potential and profitability throughout his career.
Ed has a Bachelor of Science in Accounting from Mount St. Mary’s University and has attended Executive Programs at Oxford University and Harvard Business School. He is a Certified Public Accountant in the state of New Jersey. In his free time, Ed enjoys the great outdoors, from the slopes to the beach and everything in between.
Mike brings tremendous experience adopting emerging technologies, including robotic process automation, machine learning, and artificial intelligence, to accelerate product development, integration, and deployment to his role as Medrio’s Chief Technology Officer.
Before joining Medrio in 2023, Mike served as Division CTO and SVP of Technology with digital health company Sharecare, where he accelerated cross-platform integrations and expanded the company’s machine learning, automation, and analytics capabilities.
Mike has over ten years of experience in healthcare and medical device development. He is a veteran in technology with over 25 years of experience. He has held progressive technology transformation and leadership roles with Align Technologies and Deutsche Bank and holds a Bachelor’s degree from East Carolina University.
Neil brings decades of expertise in regulatory compliance, quality management, and data privacy to his role as Medrio’s Senior Vice President and Chief Compliance Officer. With a strong focus on aligning compliance with business goals, Neil ensures Medrio’s systems and processes meet rigorous regulatory standards while enabling operational excellence.
Before stepping into his current role in 2024, Neil served as Medrio’s Vice President of Compliance, where he led critical initiatives in software validation, external audit support, and compliance training. Prior to joining Medrio in 2020, Neil founded and led VeriScientia Inc., providing global consulting on quality system development and regulatory compliance. He also held leadership roles with Signant Health and SEC Associates, bringing a wealth of experience in healthcare technology and life sciences.
A former Lieutenant Commander in the U.S. Navy, Neil earned a Master of Science in Information Technology Management from the Naval Postgraduate School and a Bachelor of Arts in History from the University of Virginia. With expertise spanning GCP, data protection, and software validation, Neil is passionate about fostering a culture of compliance and innovation at Medrio.
As Medrio’s Senior Vice President of Client Services, David Klasnick works each day to ensure our customers are able to achieve their research goals and manage their clinical trials with unrivaled confidence, ease, and support using Medrio’s eClinical technology solutions.
He oversees Medrio’s centers of excellence in implementation and onboarding, project management, professional services, data sciences, and biostatistics, as well as our 24/7 in-house technical support function.
Prior to joining Medrio, David held operations leadership roles overseeing implementation, value delivery, and account management functions with diverse healthcare organizations, including Relatient, WebMD Provider Services, and StayWell. He began his career with The Advisory Board, where he spent 11 years in progressive hospital consulting roles focused on margin improvement, technology implementation, and value delivery.
David holds a Bachelor’s degree in Business Administration and Management and a Master of Business Administration degree from the University of Denver.
As Medrio’s Senior Vice President of Marketing, Denise is responsible for building and accelerating an integrated marketing strategy and leads a high-impact team of brand, product, channel, digital, and growth marketers working in alignment with each to share stories about the “Medrio difference” with clinical research stakeholders across the globe.
Denise brings more than 20 years of healthcare marketing leadership experience to her role at Medrio, spanning healthcare technology, managed services, and acute and specialty care sectors. Prior to joining Medrio in 2022, Denise held marketing leadership roles with MatrixCare by ResMed, WebMD Provider Services (StayWell/Krames), and Aramark’s healthcare services division. She began her career with progressive marketing and public relations roles with Quincy Medical Center, a Boston-area community teaching hospital.
She holds an MBA from Widener University, a Masters of Arts in Integrated Marketing Communications from Emerson College, and a Bachelor of Arts degree in Communications from Framingham State University.
Kathy Cole, Medrio’s Vice President of Human Resources, has spent her professional career working within high-growth pharmaceutical and biotech companies and leading comprehensive human resources strategies that support the talent that is powering tomorrow’s healthcare innovations.
At Medrio, Kathy leads talent recruitment, engagement, development, and management activities in support of Medrio’s organization culture that emphasizes continual training and maintaining an A-Player mindset, promotes positive work-life balance with a remote-first workforce, and empowers the “Joy with Sprinkles of Quirkiness” that our Medrians across the globe bring to life each day.
Kathy’s breadth and depth of human resources expertise spans organizations with 80,000+ employees to an emerging pharmaceutical start-up where she was the tenth employee. She has held HR leadership roles with Windtree Therapeutics, Inc., Savient Pharmaceuticals, Inc., EpiGenesis Pharmaceuticals, and Cytogen Corporation.
She earned a Bachelor of Arts in Communications at Douglass College, Rutgers University, in New Brunswick, NJ. She later returned to Rutgers to earn a Master of Science in Industrial Relations and Human Resource Management.
As Medrio’s Vice President of Product, Mandana drives the development and execution of product strategies for Medrio’s unified eClinical solutions that leverage cutting-edge technologies to address the complex challenges facing clinical trials. She leads a team of Product Managers and Product Designers in defining, communicating and developing Medrio’s Product Roadmaps in close collaboration and partnership with Medrio’s Technology, Commercial, and Operations teams.
Mandana brings more than 25 years of healthcare industry experience spanning global health research, public health policy and prevention, home health services management, healthcare consulting and healthcare technologies to her role with Medrio.
Prior to joining Medrio, Mandana led product management teams spanning both clinical and business health tech solutions. In all roles, she employed data analytics and AI technologies in the delivery of enterprise healthcare solutions to hospitals and health systems in the US, as well as US public safety software for 911 call centers.
Mandana is a lifelong learner who remains at the forefront of emerging technologies and industry best practices, continuously seeking new ways to drive innovation and make a meaningful impact on the lives of patients and caregivers. Mandana has held roles in senior product leadership at the Advisory Board Company (now Optum) and Product Executive roles at RapidDeploy and CipherHealth.
Mandana holds a Bachelor’s degree from the University of Texas at Austin and an MPH/MBA from Emory University’s Rollins School of Public Health with a focus on Global Health and Goizueta Business School with a focus on Finance.
Spencer is a General Partner and leads the healthcare practice at TSVC, a seed stage venture fund in Los Altos, California. He spent 30 years in operating roles in the technology industry, and is a two-time founder.
Ryan Drant has been actively investing in healthcare since 1996. He specializes in investments in the medical device, healthcare services, healthcare information technology, and specialty pharma sectors. Ryan has been named four times to the Forbes Midas List of best venture capital investors. Prior to founding Questa, Ryan was a General Partner at New Enterprise Associates (NEA). He led the firm’s global healthcare investing practice and served as a member of NEA’s four-person management committee. Previously, Ryan was with the Health Care Investment Banking Group of Alex. Brown & Sons and Arthur Andersen & Co.
Mike Novotny is the founder of Medrio and was CEO for 15 years. Mr. Novotny applies 25 years of research and software experience to his vision for cloud computing in life sciences. Before founding Medrio, Mr. Novotny was CEO of Telosa, President of Ninaza, a research associate at the UN, and the VISA fraud database manager. He holds a BA from Stanford University, an MA from PUC University in Chile, and an MBA from Columbia University.
An entrepreneur from a long line of entrepreneurs, Doug Engfer has more than 25 years of executive leadership experience, focused on building productive organizations that expand their customers’ top-line revenue. Most recently, Doug co-founded invivodata (now part of ERT), serving as President, CEO, and Board Chair. invivodata permanently changed pharmaceutical clinical research by pioneering the direct collection of valid, reliable patient self-reported data. Before that, Doug founded The Windward Group (now part of Nokia), a Silicon Valley software development services firm.
Brad Sloan has been actively involved in the healthcare space for 20 years and specializes in investments in the healthcare information technology and healthcare services sectors. Prior to co-founding Questa, Brad was a senior investment professional at Parthenon Capital Partners, a growth-oriented private equity firm, where he helped lead the healthcare investment practice. Prior to Parthenon, Brad worked at Broadlane, Inc., a healthcare technology company, where he was a member of the Executive Management Committee. Brad previously worked in a variety of healthcare investment roles at MTS Health Partners and Evercore Partners. Brad started his career in the Healthcare Investment Banking Group at Bear, Stearns & Co.
Sign up to have our the latest insights delivered to your inbox.
